-+ 0.00%
-+ 0.00%
-+ 0.00%

Taysha Gene Therapies prices $200 million follow-on stock offering at $6 per share

PUBT·06/25/2026 02:33:51
Listen to the news
Taysha Gene Therapies prices $200 million follow-on stock offering at $6 per share
  • Taysha Gene Therapies priced an underwritten public offering of 32,500,001 common shares at USD 6 per share.
  • Offering also includes pre-funded warrants for 833,333 shares priced at USD 5.999 each.
  • Gross proceeds expected at about USD 200 million, excluding any exercise of the underwriters’ option.
  • Underwriters hold a 30-day option to buy up to 5,000,000 additional common shares.
  • Deal expected to close on or about June 26, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Taysha Gene Therapies Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606242233PRIMZONEFULLFEED9752395) on June 25, 2026, and is solely responsible for the information contained therein.